Two relatively unknown biotechs that are developing promising therapies in this field are Terns Pharmaceuticals ( TERN -7.64%) and Rhythm Pharmaceuticals ( RYTM -2.57%). These biotechs could soar ...
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), a clinical-stage biotech, is pioneering the use of artificial intelligence and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback